Entrada Therapeutics (TRDA) Q2 2024 Earnings

7MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.86
-0.35
0.17
0.68

Details

Expected EPS
-0.594
Actual EPS
0.68
Surprise EPS
1.27
Surprise Percent
+214.48%

Description

Entrada Therapeutics (TRDA) has reported earnings of 0.68 per share for Q2 2024.

0 Comments

Share your thoughts